SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-24-044286
Filing Date
2024-05-16
Accepted
2024-05-16 16:00:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0206194-424b4_virpax.htm 424B4 374048
2 GRAPHIC image_001.jpg GRAPHIC 11943
3 GRAPHIC image_002.jpg GRAPHIC 59970
4 GRAPHIC image_003.jpg GRAPHIC 54279
  Complete submission text file 0001213900-24-044286.txt   549340
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-278796 | Film No.: 24955360
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)